Sleep Awareness Week: What You Should Know About Sleep and Perinatal Mental Health
In recognition of Sleep Awareness Week, we’re highlighting what you should know. Explore our sleep-related blogs, podcasts, and resources.
Introducing Members of The 2026 Psychiatry Collective
Please join us in welcoming our inaugural Psychiatry Collective cohort, a select group shaping the future of women's mental health care.
For International Women’s Day, Take Action to Improve Maternal Mental Health
Whether through donations, knowledge, resources, infrastructure, advocacy, education, training, mentoring, or time, contributing to women's advancement helps create a more supportive and interconnected world.
Weekly Roundup for March 6, 2026: Recent Publications in Women’s Mental Health
This week’s roundup covers prenatal SARS-CoV-2 exposure and child neurodevelopment, cannabis use in pregnancy and related risks, and estradiol-linked mood changes during menopause.
Weekly Roundup for February 20, 2026: Recent Publications in Women’s Mental Health
Every week we review the most recent publications in women’s mental health.
Announcing our 2026 Inaugural NP Masterclass Cohort
Please join us in welcoming our pilot NP Masterclass inaugural 2026 cohort, a select group shaping the future of women's mental health care.
Weekly Roundup February 13, 2026: AI and Apps for Perinatal Depression, Pregnancy and Postpartum Sleep, Dobbs Fallout, and More
Every week we review the most recent publications in women’s mental health.
Giving Postpartum Psychosis a Place in the DSM May Be a Step in the Right Direction, But Not Enough
Including postpartum psychosis in the DSM may help improve awareness, but it is only the first step in ensuring timely recognition and effective care.
Postpartum Bipolar Disorder: Similar, But Not the Same?
Postpartum bipolar disorder appears to have a somewhat distinct clinical profile in terms of timing and symptom pattern, but current evidence suggests it is better conceptualized as a subtype of bipolar disorder rather than a fully separate diagnostic entity.
Gabapentin: A Non-Hormonal Option for the Treatment of Menopausal Vasomotor Symptoms
Current guidelines list gabapentin as a recommended nonhormonal therapy for vasomotor symptoms in women who cannot or prefer not to use hormone therapy.